This is to inform you of 2 corrections in the product recognition section of the 35th edition of the Compendium of Pharmaceuticals and Specialties (CPS).1 On page R22, the photographs for Merck Frosst Canada & Co. products Singulair (montelukast sodium) 5 mg and Singulair (montelukast sodium) 10 mg were inverted. For further information, please refer to the product monograph for Singulair (montelukast sodium) on page 1464 of the CPS.
On page R10, the photograph of Bayer Inc. Consumer Care Division product Aspirin (ASA) 325 mg tablet was replaced by Aspirin (ASA) 325 mg caplet. For further information, please refer to the product monograph for Aspirin (ASA) on page 144 of the CPS.
We apologize for any inconvenience these errors may have caused our users.
Acknowledgments
Letters may be submitted by mail, courier, email or fax. They must be signed by all authors and limited to 300 words in length. Letters that refer to articles must be received within 2 months of the publication of the article. CMAJ corresponds only with the authors of accepted letters. Letters are subject to editing and abridgement.
Email should be addressed to pubs{at}cma.ca and should indicate "Letter to the editor of CMAJ" in the subject line. A signed copy must be sent subsequently to CMAJ by fax or regular mail. Accepted letters sent by email appear in the Readers' Forum of eCMAJ (www.cma.ca/cmaj) promptly, as well as being published in a subsequent issue of the journal.
Reference
- 1.↵